Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_assertion type Assertion NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_head.
- NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_assertion wasGeneratedBy ECO_0000203 NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_provenance.
- NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_assertion wasDerivedFrom befree-20150227 NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_provenance.
- NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_assertion SIO_000772 21071687 NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_provenance.
- NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_assertion evidence source_evidence_literature NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_provenance.
- NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_assertion description "[Although GCKR CT (46%) and TT (14%) versus CC (40%) genotypes had effects on triglycerides (+0.17 mmol/L; trend, P<0.001), remnant cholesterol (+0.07 mmol/L; P<0.001), and apolipoprotein B (+4.6 mg/dL; P<0.001) similar to those of TRIB1, GCKR did not influence low-density lipoprotein cholesterol levels or risk of IHD or MI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244033.RABjSxvq5yLf8EbjnYfpD3LpWTM4i91wmMwDV-RYe_sF4130_provenance.